CLINICAL_TRIALS
research
· 2026-04-21
Clinical Trial Update: GyroStim for Post Concussion Syndrome [NA]
Summary
GyroStim is being studied in a clinical trial for post-concussion syndrome. Recruitment is currently ongoing.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Neuroscience Group | Conditions: Post Concussion Syndrome | NA | Status: RECRUITING